FDA Clearance Tracker · K191183
EyeBOX
Last checked: Nov 20, 2026Latest source record: Jul 31, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Jul 31, 2019
Substantially Equivalent
Time to decision
90 days
Received May 2, 2019. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K191183
- Device name
- EyeBOX
- Applicant
- Oculogica, Inc.
- Applicant location
- New York, NY
- Received
- May 2, 2019
- Decided
- Jul 31, 2019
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 882.1455
- Specialty
- Neurology & Neurosurgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QEA. The earliest in FDA's data is DEN170091, decided Dec 28, 2018.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K191183
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Oculogica, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- EyeBOX SNAP510(k)
K254086 · Decided Jun 5, 2026 · 169 days after receipt
Device type: Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid (QEA) · Neurology & Neurosurgery
- EyeBOX EBX-4.1510(k)
K242116 · Decided Apr 4, 2025 · 259 days after receipt
Device type: Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid (QEA) · Neurology & Neurosurgery
- EyeBOX (Model EBX-4)510(k)
K212310 · Decided Dec 22, 2021 · 152 days after receipt
Device type: Brain Injury Adjunctive Interpretive Oculomotor Assessment Aid (QEA) · Neurology & Neurosurgery
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.